Health: Parkinson’s Disease Debate
Full Debate: Read Full DebateLord Harrison
Main Page: Lord Harrison (Labour - Life peer)Department Debates - View all Lord Harrison's debates with the Department of Health and Social Care
(13 years, 7 months ago)
Lords ChamberMy Lords, I, too, congratulate my noble friend Lady Gale and all her colleagues on Minding the Gap and on producing a groundbreaking contribution to the understanding of Parkinson’s and its effects on people affected by it and on carers. I hope that the noble Earl will spare some of his time to talk about the carers, who have a particularly difficult time in caring for people with such a difficult disease as Parkinson’s. I look forward to the Government’s response and I hope that the fate that befell the multiple sclerosis review will not befall the NICE guidelines for Parkinson’s this year, when the review is taking place. It would be very helpful to have an assurance that will not happen.
The 2011 review, indeed, offers a real opportunity not only to examine the recent evidence on the new drugs and treatments for managing symptoms but to scan the full multidisciplinary range of services provided to Parkinson's people for their present effectiveness. It would be helpful if NICE could include Parkinson's in the list of conditions for which it develops quality standards, because that will help avoid any postcode lottery approach to Parkinson's which undermines the proper national and comprehensive service which my noble friend Lady Gale has already mentioned. Again, I ask: is that possible?
Also, at a time of impending NHS reorganisation, it is imperative that GP consortia, which will be at the centre of change, should also commission services once they have sought expert advice and support from Parkinson’s experts. Third sector organisations such as the Neurological Commissioning Support service, or NCS, should also be fully consulted, especially as they represent a joint initiative of the Mind, the MS Society and Parkinson’s UK. The NCS is best placed to advise GP consortia about people with long-term neurological conditions. I wonder whether we can have an assurance there.
I should, perhaps, mention a local initiative in Chester and North Wales that may qualify as a contribution to the big society espoused by the Government. Last year, with the noble Lords, Lord Wade of Chorlton and Lord Jones, I was present at the launch of a co-operative arrangement between the local MS support centre and the local Parkinson’s branch, of which I am very honoured to be the president. Indeed, we are having our Parkinson’s branch AGM in the MS support centre later on in January. Such collaboration between natural allies should be encouraged as providing added value and not just as a cover for cost-cutting.
However, the more that I have come to understand Parkinson's, the more I have come to understand the central role of the Parkinson’s specialist nurses, on which the two previous speakers commented. Those nurses stand as advisers, advocates and allies of Parkinson’s people between the GP, who seldom has the detailed knowledge, and the consultant, who seldom has sufficient time within the very busy days that occupy them. The importance of the specialist nurse is that Parkinson’s is a shape-shifter of a disease, which requires the prompt attention of expert nurses to match its every deleterious move. Some years ago in Chester our specialist nurse was axed by the local PCT, which was then experiencing financial difficulties. We fear that the new NHS commissioning changes will again imperil our specialist nurse post, which was re-established after the community worked long and hard to finance its future. Indeed, I fear for all 300 of the national team of specialist nurses for Parkinson’s, who are in place and funded by local groups, Parkinson’s UK and local PCTs. Can the noble Earl give us an assurance on maintaining the efficacy of that team?
For people with Parkinson's, maintaining personal mobility is key to leading a normal lifestyle. My local branch, for instance, has just supplied its specialist physiotherapy team with the latest laser-enhanced walking aids for their diagnostic programmes. They cost £150 but work wonders. Any move from specialist nursing to a more generalised provision of nursing will turn off the tap of such innovative approaches. Nurses are crucial advisers when it comes to mobility and passing on best practice. Indeed, one such best practice is the use of Nintendo Wii programmes that now help those who want to maintain their balance by, for instance, using a ski programme that allows you to go down ski slopes. That helps people with Parkinson’s to maintain balance. We should be encouraging all these items.
I shall end on a more amusing note. It is good that Michael J Fox, who is himself a sufferer, continues to pour money into research into Parkinson’s, but I was struck the other day that there is a new romantic comedy doing the rounds called “Love and Other Drugs”. The feature of the film is that Anne Hathaway plays the part of an early Parkinson’s sufferer. She tells us that she has enormous respect for Parkinson’s, which she has learnt about as a result of doing this romantic comedy, and she says that in the throes of a passionate embrace on one occasion she had to simulate a Parkinson’s tremor at the same time. It is interesting that something that is a reality for so many people outside is now beginning to filter in and be represented in films like this romantic comedy.
I commend again the work of the all-party group headed by my noble friend Lady Gale, and I hope that the Minister, who has always had a strong interest in all these issues, is able to give us some promising responses today.